Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/86456
Title: Acetaminophen use and risk of asthma, rhinoconjunctivitis, and eczema in adolescents : international study of asthma and allergies in childhood phase three
Authors: Beasley, Richard W.
Clayton, Tadd O.
Crane, Julian
Lai, Christopher K.W.
Montefort, Stephen
Mutius, Erika von
Stewart, Alistair W.
Authors: ISAAC Phase Three Study Group
Keywords: Acetaminophen
Asthma -- Diagnosis
Rhinocryptidae
Eczema
Issue Date: 2011
Publisher: American Thoracic Society
Citation: Beasley, R. W., Clayton, T. O., Crane, J., Lai, C. K., Montefort, S. R., Mutius, E. V., & Stewart, A. W. (2011). Acetaminophen use and risk of asthma, rhinoconjunctivitis, and eczema in adolescents: International Study of Asthma and Allergies in Childhood Phase Three. American Journal of Respiratory and Critical Care Medicine, 183(2), 171-178.
Abstract: Rationale: There is epidemiological evidence that the use of acetaminophen may increase the risk of developing asthma. Objectives: To investigate the risk of asthma and other allergic disorders associated with the current use of acetaminophen in 13- to 14-year-old children in different populations worldwide. Methods: As part of the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three, 13- to 14-year-old children completed written and video questionnaires obtaining data on current symptoms of asthma, rhinoconjunctivitis, and eczema, and a written environmental questionnaire obtaining data on putative risk factors, including acetaminophen use in the past 12 months. Measurements and Main Results: The primary outcome measure was the odds ratio (OR) of current asthma symptoms associated with acetaminophen use calculated by logistic regression. A total of 322,959 adolescent children from 113 centers in 50 countries participated. In the multivariate analyses the recent use of acetaminophen was associated with an exposure-dependent increased risk of current asthma symptoms (OR, 1.43 [95% confidence interval, 1.33–1.53] and 2.51 [95% confidence interval, 2.33–2.70] for medium and high versus no use, respectively). Acetaminophen use was also associated with an exposure-dependent increased risk of current symptoms of rhinoconjunctivitis and eczema. Conclusions: Acetaminophen use may represent an important risk factor for the development and/or maintenance of asthma, rhinoconjunctivitis, and eczema in adolescent children.
URI: https://www.um.edu.mt/library/oar/handle/123456789/86456
Appears in Collections:Scholarly Works - FacM&SMed

Files in This Item:
File Description SizeFormat 
Acetaminophen_use_and_risk_of_asthma_rhinoconjunctivitis_and_eczema_in_adolescents.pdf
  Restricted Access
1.43 MBAdobe PDFView/Open Request a copy


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.